<DOC>
	<DOCNO>NCT02862171</DOCNO>
	<brief_summary>A follow-on , open label trial ass continue safety adherence Dapivirine ( 25mg ) vaginal ring-004 healthy , HIV-negative woman</brief_summary>
	<brief_title>To Assess Continued Safety Adherence Dapivirine ( 25 mg ) Vaginal Ring-004 Healthy , HIV-negative Women</brief_title>
	<detailed_description />
	<criteria>Women must meet follow criterion eligible enrol trial : 1 . Previously enrol IPM 027 trial 2 . Available visit consent follow procedure schedule trial 3 . Using effective method contraception Enrolment Visit , intend use effective contraceptive method duration trial participation , unless postmenopausal history menses one year prior screen 4 . HIVnegative determine HIV algorithm apply Screening/Pre Enrolment 5 . Willing refrain participation another research trial use drug , vaccine , medical device microbicides duration IPM 032 trial 6 . Willing provide adequate locator information trial retention purpose reachable per local standard procedure ( e.g. , home visit telephone ; via family close neighbour contact ) ; confidentiality maintain . Women meet follow criterion NOT eligible enrol trial : 1 . Investigational product use permanently discontinue response AE ( AE consider related investigational product ) safetyrelated concern take part IPM 027 trial 2 . Participant selfreport take postexposure prophylaxis ( PEP ) within â‰¤ 2 month Screening Visit Note : Participants may enrol complete PEP regimen negative HIV test document least 2 month prior screen IPM 032 3 . Currently pregnant , intend become pregnant currently breastfeed 4 . Known drug abuse alcohol dependence 12 month prior screen 5 . Participated another research trial ( IPM 027 ) use drug , medical device , microbicides oral preexposure prophylaxis agent within 30 day prior screen 6 . Any new illness condition ( ) , chronic condition ( ) abnormal laboratory finding ( ) , opinion investigator , might put participant risk , interfere trial objective participant 's adherence trial requirement</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>